Comparison

JAK3/BTK-IN-7 European Partner

Item no. TMO-T86758-50mg
Manufacturer TargetMol
CASRN 2844387-16-0
Amount 50 mg
Quantity options 10 mg 10 mg 50 mg 50 mg
Category
Type Molecules
Specific against other
Smiles NC1=C2C(=NN(C2=NC=N1)[C@H]3CN(C(C=C)=O)CCC3)C4=C5C(=C(NC(=O)C6=CC=C(N(C)C)C=C6)C=C4)OCO5
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
JAK|||BTK
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
554, 6
Description
JAK3/BTK-IN-7 (XL-12), characterized as a JAK3/BTK inhibitor, exhibits IC 50 values of 2 nM and 14 nM for JAK3 and BTK respectively. This compound demonstrates anti-inflammatory properties and is applicable in research related to rheumatoid arthritis [1].
Pathways
Angiogenesis|||JAK/STAT signaling|||Chromatin/Epigenetic|||Tyrosine Kinase/Adaptors|||Stem Cells

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close